{"symbol":"ABT","fiscalQuarter":"Q4-2021","reportDate":"2022-01-26","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q4-2021","postBrief":{"headline":"Abbott Laboratories Beats on EPS, Stock Down 2.6%","keyNumbers":[{"metric":"EPS","actual":"$1.32","expected":"N/A","surprise":"+11.86%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No forward guidance data is available.","changes":[]},"whatItMeans":"Abbott Laboratories reported a better-than-expected EPS, exceeding estimates by nearly 12%. However, the stock fell by 2.6% following the announcement, indicating that investors may have been looking for more comprehensive revenue details or guidance. The lack of additional information from management could have contributed to the stock's decline.","metaDescription":"Abbott Laboratories (ABT) Q4 2021 earnings: EPS beat by 11.86%. Stock down 2.6%. Full breakdown."}}